Parnassus Investments, LLC Vertex Pharmaceuticals Inc Transaction History

Parnassus Investments, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$343.0 - $410.68 $25,382 - $30,390	74 Added 11.14%	738 $300,000
Q3 2023 Nov 08, 2023	BUY	$338.18 - $362.46 $16,909 - $18,123	50 Added 8.14%	664 $230,000
Q2 2023 Jul 31, 2023	SELL	$314.42 - $351.91 $47,791 - $53,490	-152 Reduced 19.84%	614 $216,000
Q1 2023 May 01, 2023	SELL	$283.23 - $323.1 $67.8 Million - $77.4 Million	-239,515 Reduced 99.68%	766 $241,000
Q4 2022 Jan 30, 2023	SELL	$285.76 - $321.48 $6.2 Million - $6.97 Million	-21,686 Reduced 8.28%	240,281 $69.4 Million
Q2 2022 Aug 05, 2022	SELL	$234.96 - $292.55 $72.7 Million - $90.5 Million	-309,518 Reduced 54.16%	261,967 $73.8 Million
Q1 2022 May 11, 2022	SELL	$221.42 - $260.97 $10.6 Million - $12.5 Million	-47,953 Reduced 7.74%	571,485 $149 Million
Q2 2021 Aug 05, 2021	BUY	$187.49 - $221.1 $116 Million - $137 Million	619,438 New	619,438 $125 Million

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Parnassus Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Parnassus Investments, LLC with notifications on news.